Characterization of miR-888 expression and regulation in endometrial cancer

作者: Adriann Marie Hovey

DOI: 10.17077/ETD.MO6VAWWG

关键词:

摘要: Endometrial cancer is the fourth most common in women and gynecological malignancy. While patient outcome has improved for majority of cancers, outlook endometrial steadily decreased. In order to address this problem, we must better understand different mechanisms involved development progression. To end, quantified expression 667 miRNAs four endometrioid adenocarcinoma serous using Taqman Low Density Arrays (TLDAs). miR-888 was one highly overexpressed both subtypes. Analysis across multiple types The Cancer Genome Atlas database revealed that selectively expressed cancer, with a significant association invasive high grade tumors. addition, predominantly carcinosarcoma, rare but deadly form cancer. Therefore, conclude marks an aggressive tumor phenotype. One top predicted targets by TargetScan progesterone receptor (PR). PR potent suppressor endometrium whose often lost advanced cancers. We mRNA panel tumors found statistically significant, negative correlation between expression. Furthermore, overexpression cell lines capable decreasing at protein level. determine if directly PR, cloned each binding sites downstream Renilla luciferase into psiCHECK2 reporter vector.

参考文章(127)
Vladimir Stanišić, David M. Lonard, Bert W. O’Malley, Modulation of steroid hormone receptor activity Progress in Brain Research. ,vol. 181, pp. 153- 176 ,(2010) , 10.1016/S0079-6123(08)81009-6
William B Pratt, Mario D Galigniana, Yoshihiro Morishima, Patrick JM Murphy, None, Role of molecular chaperones in steroid receptor action. Essays in Biochemistry. ,vol. 40, pp. 41- 58 ,(2004) , 10.1042/BSE0400041
D P McDonnell, P H Giangrande, The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Progress in Hormone Research. ,vol. 54, pp. 291- 314 ,(1999)
Douglas Dillon Taylor, Paul Henry Black, Shedding of Plasma Membrane Fragments Developmental biology (New York, N.Y. : 1985). ,vol. 3, pp. 33- 57 ,(1986) , 10.1007/978-1-4684-5050-7_3
Elisabeth Stockert, Hiromi Kumon, Tomoyasu Tsushima, Takashi Saika, Takushi Kurashige, Achim Jungbluth, Toshiro Ono, Yuji Noguchi, Yasuhiro Nagata, Gerd Ritter, Eiichi Nakayama, Lloyd J. Old, Yao Tseng Chen, Yao Tseng Chen, NY-ESO-1 Expression and Immunogenicity Associated with Transitional Cell Carcinoma: Correlation with Tumor Grade Cancer Research. ,vol. 61, pp. 4671- 4674 ,(2001)
Tannaz Toloubeydokhti, Qun Pan, Xiaoping Luo, Orhan Bukulmez, Nasser Chegini, The expression and ovarian steroid regulation of endometrial micro-RNAs. Reproductive Sciences. ,vol. 15, pp. 993- 1001 ,(2008) , 10.1177/1933719108324132
P. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, P. Chambon, Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. The EMBO Journal. ,vol. 9, pp. 1603- 1614 ,(1990) , 10.1002/J.1460-2075.1990.TB08280.X
Robert J. Kurman, Christina Isacson, Kathleen R. Cho, Ross Levine, Hironori Tashiro, Lora Hedrick, p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis American Journal of Pathology. ,vol. 150, pp. 177- 185 ,(1997)
Aurora Esquela-Kerscher, Frank J. Slack, Oncomirs — microRNAs with a role in cancer Nature Reviews Cancer. ,vol. 6, pp. 259- 269 ,(2006) , 10.1038/NRC1840
Abhipsa Dharia, Rajvir Dahiya, Masahiro Sasaki, Yuichiro Tanaka, Bong R. Oh, Sei-ichiro Fujimoto, Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Research. ,vol. 61, pp. 97- 102 ,(2001)